A Los Angeles jury has awarded $40 million to 2 girls who claimed that talcum powder manufactured by Johnson & Johnson brought about their ovarian most cancers.
The healthcare large instantly introduced its intention to attraction the legal responsibility verdict and compensatory damages.
This ruling represents the most recent growth in a protracted authorized battle over allegations that talc in Johnson’s Baby Powder and Shower to Shower physique powder is linked to ovarian most cancers and mesothelioma, a most cancers affecting the lungs and different organs. Johnson & Johnson stopped promoting powder made with talc worldwide in 2023.
Last October, one other California jury ordered J&J to pay $966 million to the household of a girl who died of mesothelioma, claiming her most cancers developed resulting from asbestos contamination within the child powder she used.
In the most recent case, the jury awarded $18 million to Monica Kent and $22 million to Deborah Schultz and her husband. “The only thing they did was be loyal to Johnson & Johnson as a customer for only 50 years,’’ said their attorney, Daniel Robinson of the Robinson Calcagnie law firm in Newport Beach, California. “That loyalty was a one-way street.’’
Erik Haas, J&J’s worldwide vice president of litigation, said in a statement that the company had won “16 of the 17 ovarian cancer cases it previously tried” and anticipated to take action once more upon interesting Friday’s verdict.
Haas referred to as the jury’s findings “irreconcilable with the a long time of unbiased scientific evaluations confirming that talc is protected, doesn’t comprise asbestos, and doesn’t trigger most cancers.”
Johnson & Johnson changed the talc in its child powder offered in most of North America with cornstarch in 2020 after gross sales declined.
In April, a U.S. chapter courtroom decide denied J&J’s plan to pay $9 billion to settle ovarian most cancers and different gynecological most cancers litiation claims primarily based on talc-related merchandise.
https://www.independent.co.uk/news/world/americas/johnson-johnson-cancer-baby-powder-los-angeles-b2884028.html